Not applicableStudy completedNCT01017497What this trial is testingOptimal Planning Target Volume With Stereotactic RadiosurgeryWho this might be right forBrain NeoplasmsBrain Cancer Duke University 49
Not applicableLooking for participantsNCT06604689What this trial is testingAI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain MetastasesWho this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)Brain Metastasases Fudan University 800
Not applicableStudy completedNCT01621906What this trial is testing18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the BrainWho this might be right forMetastatic Breast Cancer to the Brain Memorial Sloan Kettering Cancer Center 17
Testing effectiveness (Phase 2)UnknownNCT02185352What this trial is testingBevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain MetastasesWho this might be right forBreast CancerBrain Metastases National Taiwan University Hospital 120
Testing effectiveness (Phase 2)Ended earlyNCT02047747What this trial is testingA Phase II Study of Dacomitinib in Progressive Brain MetastasesWho this might be right forBrain Cancer David Piccioni, M.D., Ph.D 4
Testing effectiveness (Phase 2)Study completedNCT03711058What this trial is testingStudy of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal CancerWho this might be right forUnresectable or Metastatic Microsatellite Stable (MSS) Solid TumorMicrosatellite Stable (MSS) Colon Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05323955What this trial is testingSecondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of TucatinibWho this might be right forBrain MetastasesHuman Epidermal Growth Factor 2 Positive Carcinoma of BreastAdvanced Breast Cancer Carey Anders, M.D. 48
Testing effectiveness (Phase 2)UnknownNCT04158947What this trial is testingHER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 AloneWho this might be right forHER2-positive Breast CancerBrain Metastases xuexin he 130
Not applicableStudy completedNCT03222258What this trial is testingProspective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer PatientsWho this might be right forStage IV Breast CancerStage IV Pancreatic CancerStage IV Colon Cancer+9 more Seoul National University Hospital 444
Testing effectiveness (Phase 2)Looking for participantsNCT06315010What this trial is testingRepotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain MetastasisWho this might be right forNSCLCBrain MetastasesROS1 Gene Rearrangement MedSIR 20
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Not applicableActive Not RecruitingNCT07448662What this trial is testingLocal Treatment Strategies for Brain Metastases of Colorectal CancerWho this might be right forColorectal CancerBrain Metastases, Adult Blokhin's Russian Cancer Research Center 700
Large-scale testing (Phase 3)Study completedNCT00124761What this trial is testingA Trial Comparing Radiosurgery With Surgery for Solitary Brain MetastasesWho this might be right forNeoplasm MetastasisBrain Neoplasm Royal Adelaide Hospital 22
Early research (Phase 1)Study completedNCT02808416What this trial is testingPersonalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)Who this might be right forBrain CancerNeoplasm Metastases Guangdong 999 Brain Hospital 10
Testing effectiveness (Phase 2)WithdrawnNCT04129515What this trial is testingNovoTTF-200A + Pembrolizumab In Melanoma Brain MetastasisWho this might be right forMetastatic MelanomaMelanoma Brain Metastasis Brown University
Not applicableUnknownNCT06410040What this trial is testingA Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal MetastasisWho this might be right forALK-positive Non-small Cell Lung CancerBrain MetastasesMeningeal Metastasis Sichuan Cancer Hospital and Research Institute 28
Testing effectiveness (Phase 2)Looking for participantsNCT02896335What this trial is testingPalbociclib and Pembrolizumab In Central Nervous System MetastasesWho this might be right forMetastatic Malignant Neoplasm to BrainRecurrent Brain MetastasesProgressive Brain Metastases Massachusetts General Hospital 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT03769103What this trial is testingStudy of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLCWho this might be right forLung Cancer Non-small Cell Stage IVBrain Metastases British Columbia Cancer Agency 40
Not applicableActive Not RecruitingNCT03391362What this trial is testingStereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain MetastasesWho this might be right forBrain MetastasesSmall Cell Lung Cancer Brigham and Women's Hospital 100
Early research (Phase 1)Looking for participantsNCT07655583What this trial is testingOBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic TherapyWho this might be right forBrain MetastasisStereotactic RadiosurgeryResection+1 more M.D. Anderson Cancer Center 20